This case report describes a 49-year-old male with stage 4 chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) on an SGLT2 inhibitor and metformin who developed EuDKA and lactic acidosis following an upper respiratory infection. Here, SLC5A2 is linked to chronic kidney disease.